HUP0301647A2 - Fibrátok alkalmazása kongesztív szívelégtelenség kezelésére használható gyógyszerkészítmény előállítására - Google Patents

Fibrátok alkalmazása kongesztív szívelégtelenség kezelésére használható gyógyszerkészítmény előállítására

Info

Publication number
HUP0301647A2
HUP0301647A2 HU0301647A HUP0301647A HUP0301647A2 HU P0301647 A2 HUP0301647 A2 HU P0301647A2 HU 0301647 A HU0301647 A HU 0301647A HU P0301647 A HUP0301647 A HU P0301647A HU P0301647 A2 HUP0301647 A2 HU P0301647A2
Authority
HU
Hungary
Prior art keywords
heart failure
preparation
fibrates
congestive heart
treatment
Prior art date
Application number
HU0301647A
Other languages
English (en)
Inventor
Arduino Arduini
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority claimed from PCT/IT2001/000390 external-priority patent/WO2002009682A2/en
Publication of HUP0301647A2 publication Critical patent/HUP0301647A2/hu
Publication of HUP0301647A3 publication Critical patent/HUP0301647A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Jelen találmány a fibrátok, különösen a klofibrát alkalmazásáravonatkozik olyan gyógyszerkészítmény elállítására, amely jólhasználható a kongesztív szívelégtelenség, különösen az olyanszívelégtelenség kezelésére, amely nincs összefüggésben diszlipidémiásállapottal. Ó
HU0301647A 2000-08-01 2001-07-20 Use fibrates for the preparation of a medicament useful in the treatment of congestive heart failure HUP0301647A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000434A IT1317886B1 (it) 2000-08-01 2000-08-01 Procedimento per la preparazione di 9,10-diidro-pirrolo (2,1-b)(1,3)benzotiazepine 9-ammino sostituite.
PCT/IT2001/000390 WO2002009682A2 (en) 2000-08-01 2001-07-20 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure

Publications (2)

Publication Number Publication Date
HUP0301647A2 true HUP0301647A2 (hu) 2003-11-28
HUP0301647A3 HUP0301647A3 (en) 2009-08-28

Family

ID=11454867

Family Applications (2)

Application Number Title Priority Date Filing Date
HU0301648A HUP0301648A3 (en) 2000-08-01 2001-07-20 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines
HU0301647A HUP0301647A3 (en) 2000-08-01 2001-07-20 Use fibrates for the preparation of a medicament useful in the treatment of congestive heart failure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HU0301648A HUP0301648A3 (en) 2000-08-01 2001-07-20 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines

Country Status (23)

Country Link
US (1) US7078521B2 (hu)
EP (1) EP1305318B1 (hu)
JP (1) JP2004505089A (hu)
KR (1) KR100801269B1 (hu)
CN (1) CN100354281C (hu)
AT (1) ATE261977T1 (hu)
AU (2) AU7768701A (hu)
BR (1) BR0112974A (hu)
CA (1) CA2415050C (hu)
CZ (1) CZ294502B6 (hu)
DE (1) DE60102385T2 (hu)
DK (1) DK1305318T3 (hu)
ES (1) ES2215922T3 (hu)
HK (1) HK1059775A1 (hu)
HU (2) HUP0301648A3 (hu)
IT (1) IT1317886B1 (hu)
MX (1) MXPA03000917A (hu)
PL (1) PL202400B1 (hu)
PT (1) PT1305318E (hu)
SI (1) SI1305318T1 (hu)
SK (1) SK287190B6 (hu)
TR (1) TR200400821T4 (hu)
WO (1) WO2002010174A1 (hu)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1301965B1 (it) * 1998-07-28 2000-07-20 Sigma Tau Ind Farmaceuti Pirrolo (2,1-b)(1,3) benzotiazepine con attivita' antipsicoticaatipica.

Also Published As

Publication number Publication date
AU2001277687B2 (en) 2006-10-05
BR0112974A (pt) 2003-07-08
SI1305318T1 (en) 2004-08-31
AU7768701A (en) 2002-02-13
EP1305318A1 (en) 2003-05-02
PL365009A1 (en) 2004-12-27
SK287190B6 (sk) 2010-02-08
CA2415050C (en) 2009-10-27
US7078521B2 (en) 2006-07-18
DE60102385T2 (de) 2005-02-17
CN100354281C (zh) 2007-12-12
ATE261977T1 (de) 2004-04-15
US20030181437A1 (en) 2003-09-25
ITRM20000434A1 (it) 2002-02-01
DE60102385D1 (de) 2004-04-22
CA2415050A1 (en) 2002-02-07
ITRM20000434A0 (it) 2000-08-01
HK1059775A1 (en) 2004-07-16
CZ294502B6 (cs) 2005-01-12
MXPA03000917A (es) 2003-09-05
HUP0301647A3 (en) 2009-08-28
IT1317886B1 (it) 2003-07-15
ES2215922T3 (es) 2004-10-16
KR100801269B1 (ko) 2008-02-04
CN1443188A (zh) 2003-09-17
EP1305318B1 (en) 2004-03-17
DK1305318T3 (da) 2004-07-26
PL202400B1 (pl) 2009-06-30
PT1305318E (pt) 2004-08-31
JP2004505089A (ja) 2004-02-19
HUP0301648A2 (hu) 2003-08-28
KR20030013525A (ko) 2003-02-14
SK1262003A3 (en) 2004-03-02
TR200400821T4 (tr) 2004-07-21
CZ200311A3 (cs) 2003-05-14
WO2002010174A1 (en) 2002-02-07
HUP0301648A3 (en) 2004-06-28

Similar Documents

Publication Publication Date Title
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
HUP0003386A2 (hu) CRF antagonisták alkalmazása depresszió, kardiovaszkuláris betegségek kezelésére szolgáló gyógyszerkészítmények előállítására
SE0001899D0 (sv) New compounds
HK1086186A1 (en) Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
UA83233C2 (ru) Замещенный 2-аминотетралин для лечения депрессии
NO20032027L (no) Effektive antitumorbehandlinger
SE9701161D0 (sv) New use I
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
PT1030667E (pt) Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
HUP0301647A2 (hu) Fibrátok alkalmazása kongesztív szívelégtelenség kezelésére használható gyógyszerkészítmény előállítására
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
UY26930A1 (es) Amidas de ácido fenilciclohexanocarboxílico sustituido y su uso
MXPA03010921A (es) Uso de acetil l-carnitina en asociacion con biotina para tratamiento der pacientes con diabetes mellitus resistente a insulina tipo 2.
HUP0300876A2 (hu) Diklofenaksók alkalmazása égési sérülések helyi kezelésére használható gyógyszerkészítmény előállítására
AU7768601A (en) Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
ATE252903T1 (de) Arzneimittel zur behandlung konvulsivischer zustände
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
ATE345124T1 (de) Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia
DE60222662D1 (de) Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung
UA36576A (uk) Спосіб корекції реактивності організму у хворих на інфаркт міокарда в гострому та підгострому періодах

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees